In the latter study, the induction of cuproptosis and ferroptosis in MDS cells by ES-Cu/IKE was enhanced by modulating the xCT-GSH-GPX4 axis, providing new strategies for MDS treatment. The gene discussed is GPX4; the disease is myelodysplastic syndrome.